Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jander, S.
Right arrow Articles by Stoll, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jander, S.
Right arrow Articles by Stoll, G.
NEUROLOGY 1993;43:1809
© 1993 American Academy of Neurology

Serum and CSF levels of soluble intercellular adhesion molecule-1 (ICAM-1) in inflammatory neurologic diseases

Sebastian Jander, MD, Fedor Heidenreich, MD and Guido Stoll, MD

Department of Neurology, Heinrich-Heine-Universität, Düsseldorf, Germany.

Intercellular adhesion molecule-1 (ICAM-1), a cell surface receptor important for cellular interactions in immune responses, especially leukocyte trafficking into inflamed tissue, is released in a soluble form (sICAM-1) into the extracellular space. In this study, we measured sICAM-1 in paired serum and CSF samples from patients with inflammatory diseases of the nervous system (IND) and calculated a sICAM-1 index as a measure of the intrathecal release of ICAM-1. In comparison with noninflammatory neurologic disease (NIND) controls, we found increased sICAM-1 index levels in viral meningoencephalitis, bacterial meningitis and, to a lesser degree, multiple sclerosis but not in Guillain-Barre syndrome. Serial examination of viral meningoencephalitis patients in most cases showed a decrease of sICAM-1 index in parallel with falling cell counts and clinical improvement. Except for those in bacterial meningitis, sICAM-1 serum levels of IND patients were not significantly different from those of NIND controls. The increased intrathecal release of sICAM-1 in viral meningoencephalitis and bacterial meningitis most likely reflects activation of macrophages and lymphocytes and provides evidence for a strong local immune response that itself, in addition to the infectious agent, may damage nervous tissue.

Address correspondence and reprint requests to Dr. Sebastian Jander, Department of Neurology, Heinrich-Heine-Universität, Moorenstr. 5, D-40225 Düsseldorf, Germany.

Supported by the Deutsche Forschungsgemeinschaft SFB 194 (B6).

Received November 2, 1992. Accepted for publication in final form January 29, 1993.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
H. Echchannaoui, K. Frei, M. Letiembre, R. M. Strieter, Y. Adachi, and R. Landmann
CD14 deficiency leads to increased MIP-2 production, CXCR2 expression, neutrophil transmigration, and early death in pneumococcal infection
J. Leukoc. Biol., September 1, 2005; 78(3): 705 - 715.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
M. Rentzos, M. Michalopoulou, C. Nikolaou, C. Cambouri, A. Rombos, A. Dimitrakopoulos, E. Kapaki, and D. Vassilopoulos
Serum Levels of Soluble Intercellular Adhesion Molecule-1 and Soluble Endothelial Leukocyte Adhesion Molecule-1 in Alzheimer's Disease
J Geriatr Psychiatry Neurol, December 1, 2004; 17(4): 225 - 231.
[Abstract] [PDF]


Home page
CVIHome page
I. Glurich, S. Grossi, B. Albini, A. Ho, R. Shah, M. Zeid, H. Baumann, R. J. Genco, and E. De Nardin
Systemic Inflammation in Cardiovascular and Periodontal Disease: Comparative Study
Clin. Vaccine Immunol., March 1, 2002; 9(2): 425 - 432.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
I. Van Rhijn, L. H. Van den Berg, W. M. J. Bosboom, H. G. Otten, and T. Logtenberg
Expression of accessory molecules for T-cell activation in peripheral nerve of patients with CIDP and vasculitic neuropathy
Brain, October 1, 2000; 123(10): 2020 - 2029.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
H. C. Brown, T. T. H. Chau, N. T. H. Mai, N. P. J. Day, D. X. Sinh, N. J. White, T. T. Hien, J. Farrar, and G. D. H. Turner
Blood-brain barrier function in cerebral malaria and CNS infections in Vietnam
Neurology, July 12, 2000; 55(1): 104 - 111.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Freyer, R. Manz, A. Ziegenhorn, M. Weih, K. Angstwurm, W.-D. Docke, A. Meisel, R. R. Schumann, G. Schonfelder, U. Dirnagl, et al.
Cerebral Endothelial Cells Release TNF-{alpha} After Stimulation with Cell Walls of Streptococcus pneumoniae and Regulate Inducible Nitric Oxide Synthase and ICAM-1 Expression Via Autocrine Loops
J. Immunol., October 15, 1999; 163(8): 4308 - 4314.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
M Trojano, C Avolio, M Ruggieri, G Defazio, F Giuliani, D Paolicelli, and P Livrea
Serum soluble intercellular adhesion molecule-1 in MS: relation to clinical and Gd-MRI activity and to rIFN{beta}-1b treatment
Multiple Sclerosis, June 1, 1998; 4(3): 183 - 187.
[Abstract] [PDF]


Home page
Mult SclerHome page
M Trojano, C Avolio, M Ruggieri, F De Robertis, F Giuliani, D Paolicelli, and P Livrea
Soluble Intercellular Adhesion Molecule-1 (sICAM-1) in serum and cerebrospinal fluid of demyelinating diseases of the central and peripheral nervous system
Multiple Sclerosis, February 1, 1998; 4(1): 39 - 44.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by AAN Enterprises, Inc.